RT20 - 20MG

Retatrutide is an investigational peptide and triple receptor agonist that targets GLP-1, GIP, and glucagon receptors involved in appetite, metabolism, and glucose regulation. Research is evaluating its potential to reduce appetite, increase feelings of fullness, support significant reductions in body weight and body fat, and improve metabolic health.